FTXH vs IVV
First Trust Nasdaq Pharmaceuticals ETF vs iShares Core S&P 500 ETF
Which is better, FTXH or IVV?
Each has led over a different period.
IVV has a lower expense ratio. FTXH led over 1Y, IVV over 3Y, 5Y and the full window. IVV is less concentrated, with 38.9% of the fund in its ten largest positions against 53.9%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | FTXH | IVV |
|---|---|---|
| Expense Ratio | 0.60% | 0.03%Best |
| AUM | $1.1B | $896.5B |
| Dividend Yield | 0.70% | 1.10% |
| Holdings | 100 | 508 |
| YTD Return | +25.21%Best | +13.59% |
| 1Y Return | +43.96%Best | +17.54% |
| 3Y Return (annualized) | +18.51% | +22.46%Best |
| 5Y Return (annualized) | +11.42% | +13.28%Best |
| Volatility (annualized) | 15.2%Best | 15.4% |
| Max Drawdown | -32.1%Best | -33.9% |
| $10,000 over 5 years | $17,172 | $18,654Best |
| Top 10 Weight | 53.9% | 38.9%Best |
| Fund Family | First Trust Portfolios (US) | iShares by BlackRock (US) |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Sep 20, 2016 | May 15, 2000 |
Volatility and max drawdown are measured over the window both funds cover: Sep 22, 2016 to Oct 14, 2026 (10.1 years).
FTXH vs IVV growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 10.1 years both funds cover.
FTXH vs IVV Performance
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an ETF from First Trust Portfolios (US) and iShares Core S&P 500 ETF (IVV) is an ETF from iShares by BlackRock (US). Over the past year FTXH returned +43.96% while IVV returned +17.54%. Year to date, FTXH is up 25.21% versus a gain of 13.59% for IVV.
Over three years, FTXH compounded at +18.51% per year against +22.46% for IVV; over five years the annualized figures are +11.42% and +13.28% respectively. Across the full 10-year window we track, IVV has the edge at +14.23% annualized vs +8.04%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
IVV has been the more volatile fund, with annualized monthly volatility of 15.4% compared with 15.2% for FTXH. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -32.1% for FTXH and -33.9% for IVV. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.67. They move together some of the time, and apart the rest.
Fees and Cost Over Time
FTXH charges 0.60% per year while IVV charges 0.03%. On a $10,000 position that is $60 vs $3 annually, a gap of $57 per year that compounds over a long holding period. On income, FTXH currently yields 0.70% against 1.10% for IVV.
Holdings Overlap
67.8% of FTXH's money is in holdings IVV also owns. 5.0% of IVV's money is in holdings FTXH also owns.
The two portfolios partly overlap.
16 positions in common, counted across the 50 positions we hold weights for in FTXH and 506 in IVV, against full books of 100 and 508.
What only one of them owns
Our book lists 484 positions for IVV that do not appear in our book for FTXH (94.4% of the fund), and 31 for FTXH that do not appear in IVV (27.7%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in FTXH | Weight in IVV | Difference |
|---|---|---|---|
| LLYEli Lilly & Co. | 7.19% | 1.39% | 5.80% |
| ABBVAbbvie Inc | 7.46% | 0.69% | 6.77% |
| JNJJohnson & Johnson | 7.01% | 0.94% | 6.07% |
| MRKMerck & Co. Inc. | 7.11% | 0.54% | 6.57% |
| PFEPfizer, Inc. | 7.11% | 0.24% | 6.87% |
| VTRSViatris Inc | 3.88% | 0.03% | 3.85% |
| GILDGilead Sciences Inc | 3.60% | 0.28% | 3.32% |
| AMGNAmgen Inc | 3.41% | 0.33% | 3.08% |
| BIIBBiogen Inc | 3.69% | 0.05% | 3.64% |
| BMYBristol Myers Squibb Co | 3.33% | 0.19% | 3.14% |
67.8% of FTXH is already inside IVV.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, FTXH or IVV?
FTXH has an expense ratio of 0.60% while IVV charges 0.03%. IVV is the cheaper option, by $57 a year on a $10,000 investment.
Which performed better, FTXH or IVV?
Over the past year FTXH returned +43.96% vs +17.54% for IVV, so FTXH leads on 1-year performance. Over the longest common window we track (10 years), FTXH annualized +8.04% vs +14.23% for IVV. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, FTXH or IVV?
IVV has been the more volatile fund at 15.4% annualized versus 15.2% for FTXH. Worst drawdown: FTXH -32.1% vs IVV -33.9%.
Should I hold both FTXH and IVV?
FTXH and IVV have a monthly-return correlation of 0.67, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between FTXH and IVV?
67.8% of FTXH's money is in holdings IVV also owns. 5.0% of IVV's is in holdings FTXH also owns. They hold 16 positions in common, counted across the 50 positions we hold weights for in FTXH and 506 in IVV.
Which pays a higher dividend, FTXH or IVV?
FTXH yields 0.70% while IVV yields 1.10%, so IVV currently pays the higher dividend yield.
Is IVV better than FTXH?
IVV has a lower expense ratio. FTXH led over 1Y, IVV over 3Y, 5Y and the full window. IVV is less concentrated, with 38.9% of the fund in its ten largest positions against 53.9%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.